Consensus of Chinese experts on chimeric antigen receptor T cell therapy for adult acute B-cell lymphoblastic leukemia (2022).
10.3760/cma.j.issn.0253-2727.2022.02.001
- Collective Name:Leukemia & Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association;Group of Hematopoietic Stem Cell Transplantation and Cellular Therapy, Hematological Oncology Committee of China Anti-Cancer Association
- Publication Type:Journal Article
- MeSH:
Adult;
Antigens, CD19;
Cell- and Tissue-Based Therapy;
China;
Consensus;
Humans;
Immunotherapy, Adoptive;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy*;
Receptors, Antigen, T-Cell;
Receptors, Chimeric Antigen
- From:
Chinese Journal of Hematology
2022;43(2):89-95
- CountryChina
- Language:Chinese
